Monday, February 8, 2016

2024 EpiCast Report on Pulmonary Arterial Hypertension - Epidemiology Trend, Growth, Size, Share and Forecast


Pulmonary Arterial Hypertension (PAH) is a rare and severe condition characterized by vascular proliferation and remodeling of the small pulmonary arteries. This results in progressively increasing pulmonary vascular resistance, leading to an increase in pulmonary arterial pressure. The disease typically results in right-sided heart failure and premature death. PAH can be idiopathic, heritable, or associated with different conditions such as connective tissue disease (CTD), congenital heart disease (CHD), human immunodeficiency virus (HIV) infection, and exposure to toxins or drugs. PAH occurs twice as frequently in women as in men. Browse Full Report With TOC @ http://www.researchmoz.us/epicast-report-pulmonary-arterial-hypertension-epidemiology-forecast-to-2024-report.html
http://www.researchmoz.us/epicast-report-pulmonary-arterial-hypertension-epidemiology-forecast-to-2024-report.html

No comments:

Post a Comment